Lipella Pharmaceuticals Inc. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ed722da8-9b34-4f63-b88a-7a16d760d57e/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $536.4k | 2024-01-01 – 2024-12-31 | evidence 0001753926-25-000507 |
| FY 2023 | $449.6k | 2023-01-01 – 2023-12-31 | evidence 0001753926-24-000403 |
| FY 2022 | $184.2k | 2022-01-01 – 2022-12-31 | evidence 0001753926-23-000352 |
| FY 2021 | $259.3k | 2021-01-01 – 2021-12-31 | evidence 0001753926-23-000352 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Lipella Pharmaceuticals Inc. — all facts · Net Income · Operating Income